These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9585670)

  • 1. Improved social and language skills after secretin administration in patients with autistic spectrum disorders.
    Horvath K; Stefanatos G; Sokolski KN; Wachtel R; Nabors L; Tildon JT
    J Assoc Acad Minor Phys; 1998; 9(1):9-15. PubMed ID: 9585670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study.
    Lightdale JR; Hayer C; Duer A; Lind-White C; Jenkins S; Siegel B; Elliott GR; Heyman MB
    Pediatrics; 2001 Nov; 108(5):E90. PubMed ID: 11694674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials.
    Sturmey P
    Res Dev Disabil; 2005; 26(1):87-97. PubMed ID: 15590241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism.
    Coniglio SJ; Lewis JD; Lang C; Burns TG; Subhani-Siddique R; Weintraub A; Schub H; Holden EW
    J Pediatr; 2001 May; 138(5):649-55. PubMed ID: 11343038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using case study methods to investigate the effects of interactive intervention for children with autism spectrum disorders.
    Girolametto L; Sussman F; Weitzman E
    J Commun Disord; 2007; 40(6):470-92. PubMed ID: 17169368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism.
    Corbett B; Khan K; Czapansky-Beilman D; Brady N; Dropik P; Goldman DZ; Delaney K; Sharp H; Mueller I; Shapiro E; Ziegler R
    Clin Pediatr (Phila); 2001 Jun; 40(6):327-31. PubMed ID: 11824175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Children with autistic spectrum disorders. I: comparison of placebo and single dose of human synthetic secretin.
    Levy SE; Souders MC; Wray J; Jawad AF; Gallagher PR; Coplan J; Belchic JK; Gerdes M; Mitchell R; Mulberg AE
    Arch Dis Child; 2003 Aug; 88(8):731-6. PubMed ID: 12876177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate.
    Chez MG; Aimonovitch M; Buchanan T; Mrazek S; Tremb RJ
    J Child Neurol; 2004 Mar; 19(3):165-9. PubMed ID: 15119476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of transdermal secretin on behavior of children with autism.
    Ratliff-Schaub K; Carey T; Reeves GD; Rogers MA
    Autism; 2005 Jul; 9(3):256-65. PubMed ID: 15937041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of secretin in the treatment of childhood autism.
    Kamińska B; Czaja M; Kozielska E; Mazur E; Korzon M
    Med Sci Monit; 2002 Jan; 8(1):RA22-6. PubMed ID: 11782669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Communication and language in the autistic spectrum: autism and dysphasia].
    Martos J; Ayuda R
    Rev Neurol; 2002 Feb; 34 Suppl 1():S58-63. PubMed ID: 12447791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretin and autism: the role of cysteine.
    Connors SL; Crowell DE
    J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):795-6. PubMed ID: 10405495
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel treatments for autistic spectrum disorders.
    Levy SE; Hyman SL
    Ment Retard Dev Disabil Res Rev; 2005; 11(2):131-42. PubMed ID: 15977319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretin treatment for autistic disorder: a critical analysis.
    Patel NC; Yeh JY; Shepherd MD; Crismon ML
    Pharmacotherapy; 2002 Jul; 22(7):905-14. PubMed ID: 12126223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal secretin for autism - a case report.
    Lamson DW; Plaza SM
    Altern Med Rev; 2001 Jun; 6(3):311-3. PubMed ID: 11410075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of intellectual functioning and autism severity on outcome of early behavioral intervention for children with autism.
    Ben-Itzchak E; Zachor DA
    Res Dev Disabil; 2007; 28(3):287-303. PubMed ID: 16730944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretin and autism: a two-part clinical investigation.
    Chez MG; Buchanan CP; Bagan BT; Hammer MS; McCarthy KS; Ovrutskaya I; Nowinski CV; Cohen ZS
    J Autism Dev Disord; 2000 Apr; 30(2):87-94. PubMed ID: 10832772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The communication of autistic spectrum children in group activities].
    Cardoso C; Fernandes FD
    Pro Fono; 2004; 16(1):67-74. PubMed ID: 15109109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled trial of porcine versus synthetic secretin for reducing symptoms of autism.
    Unis AS; Munson JA; Rogers SJ; Goldson E; Osterling J; Gabriels R; Abbott RD; Dawson G
    J Am Acad Child Adolesc Psychiatry; 2002 Nov; 41(11):1315-21. PubMed ID: 12410073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint attention, language, social relating, and stereotypical behaviours in children with autistic disorder.
    Delinicolas EK; Young RL
    Autism; 2007 Sep; 11(5):425-36. PubMed ID: 17942456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.